Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Applied Genomics logo — Innovative tools for advanced cancer detection and classific...

Applied Genomics

Innovative tools for advanced cancer detection and classification through comprehensive gene and protein expression analysis.

Founded 2000 Biotechnology

General Information

Company Name Applied Genomics
Founded Year 2000
Industries Biotechnology
Social

Get notified when Applied Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Applied Genomics

Applied Genomics is a biotechnology startup that is focused on developing innovative tools for advanced cancer detection and classification through comprehensive gene and protein expression analysis. Founded in 2000, the company utilizes complex gene expression data to facilitate antibody production and generate extensive protein expression datasets from thousands of tumor tissues. This approach has led to the discovery of a new method for classifying cancer, which has the potential to explain the clinical variations among patients that have puzzled clinicians for years. The company's innovative approach and the potential impact of their work in the field of cancer detection and classification make Applied Genomics an intriguing investment opportunity for those interested in the biotechnology sector. As the company continues to make strides in its research and development efforts, it presents the possibility of revolutionizing the way cancer is understood and treated, thereby offering the potential for substantial returns for venture capital investors.

Taxonomy: cancer detection, gene expression analysis, protein expression analysis, antibody production, tumor tissues, classification of cancer, clinical variation, genomics tools, medical research

No funding data available for Applied Genomics yet.

Get notified when Applied Genomics raises funding

Applied Genomics Alternatives & Competitors

Applied Genomics vs
Oncolines B.V.
Oncolines B.V. The Netherlands

Precision medicine services for oncology and cancer immunotherapy

21 employees
Health Care
Applied Genomics vs
Strand Therapeutics
Strand Therapeutics United States

Where synthetic biology meets RNA therapeutics

Series A
121 employees
Biotechnology, Health and Wellness
Applied Genomics vs
Octamer
Octamer

Pioneering pharmaceuticals for AIDS and cancer using advanced gene expression insights.

Series Unknown
2-10 employees
Biotechnology

FAQ About Applied Genomics

Innovative tools for advanced cancer detection and classification through comprehensive gene and protein expression analysis.
Applied Genomics was founded in 2000.
Applied Genomics operates in the following industries: Biotechnology.
Top alternatives and competitors to Applied Genomics include Oncolines B.V., Strand Therapeutics, Octamer, Pathwork Diagnostics, Protein Alternatives SL (PROALT). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Applied Genomics and Oncolines B.V. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Applied Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy